BACKGROUND/RATIONALE: Image-guided needle biopsies are commonly used to diagnose musculoskeletal tumors, but nondiagnostic (ND) results can delay diagnosis and treatment. It is important to understand which factors or diagnoses predispose to a ND result so that appropriate patient education or a possible change in the clinical plan can be made. Currently it is unclear which factors or specific lesions are more likely to lead to a ND result after image-guided needle biopsy. QUESTIONS/PURPOSES: We therefore identified specific factors and diagnoses most likely to yield ND results. We also asked whether an image-guided needle biopsy of bone and soft tissue lesions is an accurate and clinically useful tool. METHODS: We retrospectively reviewed data from a prospectively collected database for a case-control study of 508 image-guided needle biopsies of patients with suspected musculoskeletal tumors between 2003 and 2008. RESULTS: The interpretations of 453 of the 508 (89%) needle biopsies were accurate and clinically useful. Forty-five biopsies (9%) were ND and 10 (2%) were incorrect (IC). Bone lesions had a higher ND rate than soft tissue lesions (13% vs. 4%). The specific diagnosis with the highest ND rate was histiocytosis. Elbow and forearm locations had higher ND rates than average. Malignant tumors had a higher IC rate than benign tumors (5% vs. 0%); fibromyxoid sarcoma and rare subtypes of osteosarcoma had higher IC rates than other diagnoses. Repeat needle or open biopsies were performed in 71 (14%) patients. Bone lesions were more likely than soft tissue lesions to require repeat biopsies (18% vs. 9%). CONCLUSIONS: A high rate of accuracy and clinical usefulness is possible with image-guided needle biopsies of musculoskeletal lesions. We believe these biopsies appropriate in selected circumstances but a key factor for appropriate use is an experienced musculoskeletal tumor team with frequent communication to correlate clinical, radiographic, and histologic information for each patient.
BACKGROUND/RATIONALE: Image-guided needle biopsies are commonly used to diagnose musculoskeletal tumors, but nondiagnostic (ND) results can delay diagnosis and treatment. It is important to understand which factors or diagnoses predispose to a ND result so that appropriate patient education or a possible change in the clinical plan can be made. Currently it is unclear which factors or specific lesions are more likely to lead to a ND result after image-guided needle biopsy. QUESTIONS/PURPOSES: We therefore identified specific factors and diagnoses most likely to yield ND results. We also asked whether an image-guided needle biopsy of bone and soft tissue lesions is an accurate and clinically useful tool. METHODS: We retrospectively reviewed data from a prospectively collected database for a case-control study of 508 image-guided needle biopsies of patients with suspected musculoskeletal tumors between 2003 and 2008. RESULTS: The interpretations of 453 of the 508 (89%) needle biopsies were accurate and clinically useful. Forty-five biopsies (9%) were ND and 10 (2%) were incorrect (IC). Bone lesions had a higher ND rate than soft tissue lesions (13% vs. 4%). The specific diagnosis with the highest ND rate was histiocytosis. Elbow and forearm locations had higher ND rates than average. Malignant tumors had a higher IC rate than benign tumors (5% vs. 0%); fibromyxoid sarcoma and rare subtypes of osteosarcoma had higher IC rates than other diagnoses. Repeat needle or open biopsies were performed in 71 (14%) patients. Bone lesions were more likely than soft tissue lesions to require repeat biopsies (18% vs. 9%). CONCLUSIONS: A high rate of accuracy and clinical usefulness is possible with image-guided needle biopsies of musculoskeletal lesions. We believe these biopsies appropriate in selected circumstances but a key factor for appropriate use is an experienced musculoskeletal tumor team with frequent communication to correlate clinical, radiographic, and histologic information for each patient.
Authors: John A Carrino; Bharti Khurana; John E Ready; Stuart G Silverman; Carl S Winalski Journal: J Bone Joint Surg Am Date: 2007-10 Impact factor: 5.284
Authors: Manjiri M Didolkar; Megan E Anderson; Mary G Hochman; Julia G Rissmiller; Jeffrey D Goldsmith; Mark G Gebhardt; Jim S Wu Journal: Clin Orthop Relat Res Date: 2013-07-17 Impact factor: 4.176
Authors: Michael G Fox; Jon K Marti; Keith R Bachmann; Robin D LeGallo; William C Foster Journal: Skeletal Radiol Date: 2014-09-26 Impact factor: 2.199
Authors: Irene Barrientos-Ruiz; Eduardo José Ortiz-Cruz; José Serrano-Montilla; Daniel Bernabeu-Taboada; Jose Juan Pozo-Kreilinger Journal: Clin Orthop Relat Res Date: 2016-09-21 Impact factor: 4.176
Authors: Connie Y Chang; Ambrose J Huang; Miriam A Bredella; Martin Torriani; Elkan F Halpern; Daniel I Rosenthal; Dempsey S Springfield Journal: Skeletal Radiol Date: 2015-09-04 Impact factor: 2.199
Authors: Martin Thaler; Ismail Khosravi; Andreas Leithner; Panayiotis J Papagelopoulos; Pietro Ruggieri Journal: Int Orthop Date: 2020-05-26 Impact factor: 3.075